These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36620541)
1. Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma. Pan YQ; Xiao Y; Li Z; Tao L; Chen G; Zhu JF; Lv L; Liu JC; Qi JQ; Shao A Front Oncol; 2022; 12():1071100. PubMed ID: 36620541 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ Front Oncol; 2022; 12():1022097. PubMed ID: 36300102 [TBL] [Abstract][Full Text] [Related]
3. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma. Hu J; Wang T; Chen Q Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related]
5. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models. Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990 [TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis identifies Yang H; Wei X; Zhang L; Xiang L; Wang P Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552 [TBL] [Abstract][Full Text] [Related]
8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804 [TBL] [Abstract][Full Text] [Related]
9. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; AbrĂ£o FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis. Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y Front Immunol; 2022; 13():950001. PubMed ID: 36091041 [TBL] [Abstract][Full Text] [Related]
13. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis. Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S Front Genet; 2020; 11():625977. PubMed ID: 33584817 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Genomic Instability of m Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906 [No Abstract] [Full Text] [Related]
15. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
16. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma. Li X; Li B; Ran P; Wang L Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725 [TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma. Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231 [TBL] [Abstract][Full Text] [Related]
18. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma. Gao L; Zhang L BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211 [TBL] [Abstract][Full Text] [Related]
19. Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs. Zheng M; Zhou H; Xie J; Zhang H; Shen X; Zhu D J Thorac Dis; 2022 Dec; 14(12):4828-4845. PubMed ID: 36647499 [TBL] [Abstract][Full Text] [Related]
20. Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma. Fei X; Hu C; Wang X; Lu C; Chen H; Sun B; Li C Front Cell Dev Biol; 2021; 9():751490. PubMed ID: 34820377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]